Prelude Capital Management’s Jasper Therapeutics JSPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,450	Closed	-$98.6K	–	1130
2023 Q1	$98.6K	Buy	+5,450	New	+$98.6K	0.01%	854
2021 Q3	–	Sell	-10,100	Closed	-$1M	–	1542
2021 Q2	$1M	Hold	10,100	–	–	0.03%	472
2021 Q1	$1M	Buy	+10,100	New	+$1M	0.03%	365